Downloads
Online IPO
Online KYC
e-KYC
+919998510543
Live Trading
Send "Hi" to get your Back Office details.
Click Here -
https://wa.me/+919998510543
x
Home
About Us
Market
Equity
IPO
Derivatives
Currency Derivative
Authorised Person
Install Dealer Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
List of AP
Client
Install Solo Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
Install ACMP PRO Android Mobile App
Install ACMP PRO iPhone Mobile App
COLLATERAL INFORMATION
6 KYC Updation
NSDL E-VOTING
CDSL E-Voting
NSDL Nomination Online
NSDL e-Services
NSDL – Online Account Closure cum Transfer Request
ACML Announcement
communique
Announcement
Contact us
CAREERS
Home
About Us
Market
Equity
IPO
Derivatives
Currency Derivative
Authorised Person
Install Dealer Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
List of AP
Client
Install Solo Terminal
Data from Year 2022-23 onward
Historical Data from 2017-18 to 2022-23
Historical Data from 2010-11 to 2016-17
Install ACMP PRO Android Mobile App
Install ACMP PRO iPhone Mobile App
COLLATERAL INFORMATION
6 KYC Updation
NSDL E-VOTING
CDSL E-Voting
NSDL Nomination Online
Announcement
communique
Announcement
Contact us
CAREERS
IPO
Home
IPO
IPO Synopsis
Forthcoming IPO
Open IPO
Close IPO
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
IPO Synopsis
Global Health Ltd
Registered Office:
Medanta-Mediclinic,E-18 Defence Colony , New Delhi - 110024 , New Delhi , India.
Phone : Fax:
Email :
compliance@medanta.org
Website :
www.medanta.org
Initial public offering of 65,641,952* equity shares of face value of Rs. 2 each ("Equity Shares") of Global Health Limited (The "Company" or the "Company" or the "Issuer") for cash at a price of Rs. 336 per equity share (including a premium of Rs. 334 per equity share) (the "Offer Price") aggregating to Rs. 2205.57 crores* (the "Offer") comprising a fresh issue of 14,880,952* equity shares by the company aggregating up to Rs. 500.00 crores (the "Fresh Issue") and an offer for sale of 50,761,000 equity shares aggregating to Rs. 1705.57 crores* (the "Offer for Sale") comprising 50,661,000 equity shares aggregating to Rs. 1702.21 crores* by Anant Investments (the "Investor Selling Shareholder") and 100,000 equity shares aggregating to Rs. 3.36 crores* by Sunil Sachdeva (jointly held with Suman Sachdeva) (the "Individual Selling Shareholders", and along with investor selling shareholder, the "Selling Shareholders" and such equity shares offered by the selling shareholders, the "Offered Shares"). The offer shall constitute 24.46%* of the fully diluted post-offer paid-up equity share capital of the company. The face value of the equity share is Rs. 2 each and the offer price is 168 times the face value of equity shares. *Subject to finalization of the basis of allotment Bids can be made for a minimum of 44 equity shares and in multi-les of 44 equity shares thereafter.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
03-Nov-22
07-Nov-22
R
s
336.00-0.00
R
s
0.00-0.00
Minimum Application for shares in Nos :44 Further Multiples of :44
R
s
Cr
Lead Managers to the Issue
Project Cost
476.70
Credit Suisse Securities (India) Pvt Ltd
Project Financed through Current Offer
2205.57
Post Issue Equity Share Capital
53.64
Issue Price
R
s
336.00
Projects
Repayment/Prepayment of Borrowings in the Part of GHPPL & MHPL
General Corporate Purposes
Promoted By
Naresh Trehan
Listing At
BSE
NSE
Registrar to the Issue
KFin Techologies Ltd